CHRISTIANSON MARK (Business Development Director) sold 6.0% of their position (13.72K shares) of NEUROONE MEDICAL TECHNOLOGIES CORP on the open market
Open‑market sale worth $11.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/12/2026ACC: 0001709738-26-000007
Officer· Business Development Director
Since Feb 2026
-13.72K
Net shares
Net seller
$11.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
13.72K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−11.61K
Price / share
$0.80
Trade value
$9.29K
% of position
5.1%
3/10/2026
228.92K→217.31K
Common Stock
Direct
Shares
−2.11K
Price / share
$0.80
Trade value
$1.69K
% of position
1.0%
3/11/2026
217.31K→215.20K
Total
Net shares
−13.72K
Net value
-$10.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/10/2026 | S · Sale | −11.61K | $0.80 | $9.29K | 5.1% | 228.92K | 217.31K |
| Common Stock Direct | 3/11/2026 | S · Sale | −2.11K | $0.80 | $1.69K | 1.0% | 217.31K | 215.20K |
| Total | −13.72K | -$10.98K | ||||||
Derivative Transactions0
No derivative transactions reported